Hot Features
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. Mark J. HirschhornExec. VP, COO & CFO | -10,76k | 104,81k | Vente | 9,74 | 38,20k | -21,98% |
| 2026-06-01 | Ms. Phyllis I. GotlibPresident of Amwell International | -3,57k | 34,80k | Vente | 9,74 | 190,75k | -1,84% |
| 2026-06-01 | Mr. Paul Francis McNeiceVP of Accounting | -112,00 | 1,09k | Vente | 9,74 | 10,50k | -1,06% |
| 2026-05-07 | Dr. Ido SchoenbergChairman & CEO | 670,00 | 4,94k | Achat | 7,37 | 277,92k | 0,24% |
| 2026-04-01 | Ms. Phyllis I. GotlibPresident of Amwell International | -3,71k | 19,64k | Vente | 5,30 | 177,61k | -2,04% |
| 2026-04-01 | Mr. Dan ZamanskyChief Product & Technology Officer | -5,58k | 29,55k | Vente | 5,30 | 66,44k | -7,74% |
| 2026-04-01 | Mr. Paul Francis McNeiceVP of Accounting | -383,00 | 2,03k | Vente | 5,30 | 10,62k | -3,48% |
| 2026-03-02 | Mr. Dan ZamanskyChief Product & Technology Officer | -2,47k | 13,47k | Automatic Disposition | 5,45 | 58,22k | -4,07% |
| 2026-03-02 | Mr. Mark J. HirschhornExec. VP, COO & CFO | -10,80k | 56,57k | Vente | 5,24 | 26,57k | -28,89% |
| 2026-03-02 | Ms. Phyllis I. GotlibPresident of Amwell International | -3,57k | 18,72k | Vente | 5,24 | 170,53k | -2,05% |
| 2026-03-02 | Mr. Paul Francis McNeiceVP of Accounting | -130,00 | 681,20 | Vente | 5,24 | 2,93k | -4,24% |
| 2026-01-02 | Mr. Dan ZamanskyChief Product & Technology Officer | -6,24k | 30,28k | Vente | 4,85 | 39,64k | -13,61% |
| 2026-01-02 | Ms. Phyllis I. GotlibPresident of Amwell International | -3,71k | 17,98k | Vente | 4,85 | 167,64k | -2,16% |
| 2026-01-02 | Mr. Paul Francis McNeiceVP of Accounting | -384,00 | 1,86k | Vente | 4,85 | 3,06k | -11,14% |
| 2025-12-18 | Ms. Deborah C. JacksonIndependent Director | -612,00 | 2,88k | Vente | 4,71 - 4,75 | 18,24k | -3,25% |
| 2025-12-01 | Mr. Paul Francis McNeiceVP of Accounting | -113,00 | 458,47 | Vente | 4,06 | 3,45k | -3,17% |
| 2025-12-01 | Ms. Phyllis I. GotlibPresident of Amwell International | -3,57k | 14,50k | Vente | 4,06 | 165,83k | -2,11% |
| 2025-10-01 | Mr. Paul Francis McNeiceVP of Accounting | -332,00 | 2,03k | Vente | 6,11 | 3,56k | -8,53% |
| 2025-10-01 | Ms. Phyllis I. GotlibPresident of Amwell International | -4,96k | 30,28k | Vente | 6,11 | 161,11k | -2,99% |
| 2025-09-15 | Ms. Deborah C. JacksonIndependent Director | -4,53k | 29,74k | Automatic Disposition | 6,56 | 18,85k | -19,38% |
| 2025-09-03 | Mr. Dan ZamanskyChief Product & Technology Officer | -25,61k | 173,41k | Vente | 6,77 | 32,08k | -44,39% |
| 2025-09-02 | Ms. Deborah C. JacksonIndependent Director | -4,53k | 30,76k | Vente | 6,79 | 23,38k | -16,23% |
| 2025-09-02 | Ms. Phyllis I. GotlibPresident of Amwell International | -4,78k | 32,42k | Vente | 6,78 | 152,25k | -3,04% |
| 2025-09-02 | Mr. Paul Francis McNeiceVP of Accounting | -113,00 | 766,31 | Vente | 6,78 | 3,89k | -2,82% |
| 2025-08-19 | Ms. Deborah C. JacksonIndependent Director | -4,53k | 32,18k | Automatic Disposition | 7,10 | 27,92k | -13,96% |
| 2025-07-01 | Mr. Paul Francis McNeiceVP of Accounting | -331,00 | 2,86k | Vente | 8,63 | 7,86k | -4,04% |
| 2025-07-01 | Ms. Phyllis I. GotlibPresident of Amwell International | -4,96k | 42,77k | Vente | 8,63 | 107,03k | -4,43% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.